Davita Steubenville Home Training Center is a medicare approved dialysis facility center in Steubenville, Ohio and it has 6 dialysis stations. It is located in Jefferson county at 1799 Sinclair Avenue Suite 2, Steubenville, OH, 43952. You can reach out to the office of Davita Steubenville Home Training Center at (740) 346-2740. This dialysis clinic is managed and/or owned by Davita. Davita Steubenville Home Training Center has the following ownership type - Profit. It was first certified by medicare in January, 2014. The medicare id for this facility is 362801 and it accepts patients under medicare ESRD program.
| Name | Davita Steubenville Home Training Center |
|---|---|
| Location | 1799 Sinclair Avenue Suite 2, Steubenville, Ohio |
| No. of Dialysis Stations | 6 |
| Medicare ID | 362801 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1799 Sinclair Avenue Suite 2, Steubenville, Ohio, 43952 | |
| (740) 346-2740 | |
| Not Available |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
| NPI Number | 1619221132 |
| Organization Name | Steubenville Home Training |
| Doing Business As | Barrington Dialysis Llc |
| Address | 1799 Sinclair Ave Steubenville, Ohio, 43953 |
| Phone Number | (740) 346-2740 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 3 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 2 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
| Adult patients getting regular peritoneal dialysis at the center | 14 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 97 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 97 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita Steubenville Home Training Center with elevated calcium levels.
| Patients with hypercalcemia | 20 |
| Hypercalcemia patient months | 138 |
| Patients with Serumphosphor | 21 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 3 |
| Patient months included in arterial venous fistula and catheter summaries | 17 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 15 |
| Hospitalization Rate in facility | 190.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 573.5 |
| Hospitalization Rate: Lower Confidence Limit | 69.2 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita Steubenville Home Training Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 37.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 63.8 |
| Readmission Rate: Lower Confidence Limit | 16 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
To keep drinking water clean, experts are constantly monitoring our supply to check it for contaminants. Now laser technology will give them a helping hand: a new system automatically analyzes water samples at the waterworks itself.
A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.
After an accident that involved a subcontractor at a Brisbane CBD building site, workers have refused to return to work until they are satisfied with the safety arrangements. The subcontractor Braedon Webber, 25 is still in an induced coma this morning after being trapped between a piece of equipment and a concrete beam at the Laing O'Rourke tower at 123 Albert Street shortly before 7am yesterday.
› Verified 8 days ago